Good morning :)
$
₹
Abbott Laboratories

Abbott Laboratories

ABT

NYSE
Asset Logo

Abbott Laboratories

ABT

NYSE
$103.091.12% (+1.14)
$
₹
$103.091.12% (+1.14)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Healthcare

Medical Devices

Large Cap

With a market cap of $176.4B the stock is ranked 94

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

32.99
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

3.45
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$3.09
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

1.87
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

11.65%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

2.4%

Analyst Ratings & Forecast
Analyst Ratings & Forecast

Based on 27 analysts' reports

Buy
20 analysts
Hold
7 analysts
Sell
0 analyst

Analysts expect a +17.91% price upside over the next year

Current Price$103.09
Target Price$120.20

Company Profile

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

Peers

Peers

Danaher Corporation
DHR
Danaher Corporation
P/E Ratio
35.73
35.73
1Y Return
7.99%
7.99%
Buy Reco %
88.00
88.00
Intuitive Surgical Inc
ISRG
Intuitive Surgical Inc
P/E Ratio
42.38
42.38
1Y Return
12.91%
12.91%
Buy Reco %
66.66
66.66
Medtronic PLC
MDT
Medtronic PLC
P/E Ratio
22.40
22.40
1Y Return
1.15%
1.15%
Buy Reco %
53.12
53.12
Stryker Corporation
SYK
Stryker Corporation
P/E Ratio
28.58
28.58
1Y Return
25.08%
25.08%
Buy Reco %
68.75
68.75
Boston Scientific Corp
BSX
Boston Scientific Corp
P/E Ratio
17.40
17.40
1Y Return
54.89%
54.89%
Buy Reco %
91.17
91.17

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Devices

Valuation

Returns

Forecast

StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Abbott Laboratories 32.993.451.87
Danaher Corporation35.732.671.19
Intuitive Surgical Inc42.387.171.71

Price Comparison

Price Comparison

1 Month

1 Year

5 Years

Loading...

Financials

Financials

Income

Balance Sheet

Cash Flow

11.3
1.6
11.4
1.7
11.1
1
12.5
0.9
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue9.9610.3710.6310.9710.3511.1411.3611.4511.1612.59
Net Income1.221.301.649.221.321.771.641.771.070.92
Net Profit Margin12.29%12.54%15.47%84.09%12.79%15.96%14.46%15.49%9.64%7.36%
See CostsAll values in $ Billion

Frequently asked questions

Frequently asked questions

  1. Abbott Laboratories (ABT) share price today is $103.09 as of September 15, 2026 at 1:30 AM IST. The stock touched a day high of $104.34 and a day low of $102.61.

  2. Abbott Laboratories stock trades on NYSE under the ticker symbol ABT.

  3. Abbott Laboratories's market capitalization is $176.41B as of September 15, 2026 at 1:30 AM IST.

  4. Abbott Laboratories's price-to-earnings (P/E) ratio is 32.99 as of September 14, 2026.

  5. Abbott Laboratories's price-to-book (P/B) ratio is 3.45 as of September 14, 2026.

  6. Yes, Abbott Laboratories pays a dividend, with a current dividend yield of 2.4%.

  7. Yes, You can buy Abbott Laboratories shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  8. Indian investors can buy Abbott Laboratories shares in three steps: 1. Search Abbott Laboratories on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  9. Since Abbott Laboratories trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  10. Indian investors can start investing in Abbott Laboratories (ABT) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.0969 shares at the current price of $103.09.

Loading...